May 8, 2020 News by Patricia Inacio, PhD ‘Transcient’ Damage to CNS Seen with Chemotherapy Used in Stem Cell Transplants for MS A high-dose chemotherapy combination given to wipe out the immune system before its rescue withĀ autologous hematopoietic stem cell transplant (aHSCT)Ā can cause “transient” damage to neurons and supporting cells of the central nervous system in people with aggressive multiple sclerosis (MS), a Canadian study reports. Nonetheless, its researchers believe…
December 21, 2018 News by Patricia Inacio, PhD Stem Cell Transplant Lessens Disability and Relapses in RRMS Patients, Phase 2 Trial Shows Treatment withĀ autologous hematopoietic stem cell transplantĀ (aHSCT) led to a sustained decrease in disability and almost no clinical relapses in patients withĀ relapsing-remitting multiple sclerosisĀ (RRMS)Ā who had failed to respond to prior immunosuppressive therapies, an Australian Phase 2 trial shows. Trial findings were published in the study, āProspective phase…
January 11, 2018 Columns by Jennifer (Jenn) Powell Moving into the New Year with MS: Resolute to Live Each Day I have always loved the start of New Year’s;Ā tabula rasa,Ā clean slate. Much like a snake shedding its skin, we leave behind the old and embrace the new, or at least accept such. While Dec. 31 is ripe with well-intentioned resolutions, I avoid promising myself anything simply because…
August 31, 2016 Columns by admin Welcome or Not, FDA Focuses on Stem Cell Treatments News that the U.S. Food and Drug Administration (FDA) is to hold a public hearing next month to consider greater oversight of stem cell clinics operating in the country is as welcome as it is late. I say “late” because, while the regulators have been twiddling their fingers,…
August 17, 2016 Columns by admin New Pre-HSCT Treatment May Be the Future, but HSCT with Lower Dose Chemo is Right Choice for MS Patients Now News that scientists in the U.S. are working to find a new pre-HSCT treatment to carry out stem cell transplants without the need for chemotherapy, as published in Multiple Sclerosis News Today, leaves me with mixed feelings. While such a development could potentially be great news and an…
August 15, 2016 News by Patricia Silva, PhD New Pre-HSCT Treatment May Make Stem Cell Transplants a Safer Option for MS Patients Scientists at Stanford University School of Medicine have developed a method for stem cell transplants that may doĀ away with the need for prior systematic treatment with chemotherapy or radiotherapy. If successful, stem cell transplants could be an option for patients with multiple sclerosis (MS), an option nowĀ limited by the…
August 3, 2016 Columns by admin Stem Cell Clinics Under Critical Scrutiny in US Stem cell clinics are proliferating in the U.S., where there are now 570 in operation, according to a paper quoted by the New York Times. And concerns are being raised that these clinics are often operating and making claims beyond those allowed by the countryās public health regulatory…
June 14, 2016 News by Patricia Silva, PhD Aggressive Stem Cell Transplant Approach Halts MS for Years, But Risks are High Autologous haematopoietic stem cell transplantation (aHSCT) has been used to stop autoimmune processes in multiple sclerosis (MS), althoughĀ the treatment is not effectiveĀ for every person. Now, an improved version of the technique is showing astonishingly good results, with patients free ofĀ both the need for treatment and the risk of relapses for…
June 10, 2016 by admin Aggressive Stem Cell Therapy Stops MS Relapses, According to Long-term Clinical Trial Stem cell treatment has been proven to both halt MS clinical relapses and the development of new brain lesions over a prolonged period, according to the results of a new study. The results, achieved in 23 out of 24 patients in a Phase 2 clinical trial, were published in…
February 2, 2016 News by admin Individual with PPMS Shares His Experience of Undergoing Stem Cell Therapy Geoff Flynn,Ā 42, was diagnosed with multiple sclerosis (MS) two and a half years ago. As unsettling as that diagnosis was, more troubling ā both then and now ā were the five long years of struggle it took for him to get a proper evaluation as to the cause ofĀ his neurological…